MagView

We can finally share that we're doing big things together with Clairity Inc. and Myriad Genetics to identify more women at risk for breast cancer!

For the first time ever, AI image-based risk, history-based risk models, and genetic risk insights are available in one integrated platform. This means clinicians can now see a more complete picture of a woman's risk and get her the follow-up and care she needs.

We're proud to be advancing breast cancer prevention and early detection alongside some of the best in business.

Come see us at RSNA booth #2507 to learn more!

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health Actionable offering helps enable earlier, more personalized breast cancer interventionsBOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView, today announced a joint collaboration in an effort to identify more women a...

A better breast imaging experience for patients and clinicians starts with a solid workflow.

MagView has spent decades strengthening the processes that keep breast centers running smoothly. From reducing bottlenecks to closing critical gaps, we help teams deliver high-quality breast imaging.

Stop by booth #2507 at RSNA or visit our website to request a demo today to learn how we can help your mammography program and high-risk screening program run more efficiently.